List view / Grid view
New research projects that aim to improve the complex formulation processes used to manufacture products such as toothpastes, inhalers, films that coat solar cells and pharmaceuticals are to receive significant funding from the Engineering and Physical Sciences Research Council (EPSRC).
9 March 2017 | By European Pharmaceutical Review
EFPIA, EBE and IFPMA issue joint guidance for prescribers on switching between original reference biologics and biosimilars...
A defining characteristic of inhaled drug delivery is variability in the dose received by the patient, as a result of physiology, for example, or the technique applied during use. This variability directly affects clinical outcomes so reducing it to a minimum is an important goal for the industry...
For the pharmaceutical scientist, the journey of an active molecule from the end of its synthetic pathway and crystallisation to its ultimate site of action is a fascinating one, and one that is necessary to understand...
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
Understanding the effect of API changes in pharmaceutical processing; Improving the consistency of MDI drug delivery; and Expert Views with DDF Summit and Eurofins Lancaster Laboratories...
22 February 2017 | By Professor Josep Tabernero, Chair of the ESMO Cancer Medicines Working Group
Dr Josep Tabernero explains the benefits of biosimilars, showing how they can create sustainable, safe and affordable access to medicine globally...
The first part of an in-depth article on Quality by Design (QbD), published in European Pharmaceutical Review in December 2016, focused on designing quality in to a pharmaceutical drug product by considering dosage form design, and understanding the importance of active pharmaceutical ingredients’ (APIs’) and excipients’ properties.
21 February 2017 | By Viavi Solutions Inc.
This webinar presented the use of MicroNIR PAT for monitoring the endpoint of powder blending operations and discussed challenges that need to be addressed for successful implementation...
In this whitepaper, Quotient Clinical discuss poorly soluble drugs and how they have developed an innovative approach to identify and overcome these solubility challenges...
17 February 2017 | By Niamh Marriott, Digital Editor
The US Food and Drug Administration (FDA) has accepted Mylan and Biocon's biologics license application for MYL-1401H, a proposed biosimilar to Neulasta...
12 January 2017 | By Niamh Marriott, Digital Editor
This product is a proposed biosimilar to branded trastuzumab, which is indicated to treat certain HER2-positive breast cancers...
10 January 2017 | By Charles Ischi AG | Kraemer Elektronik
EPM talks to Charles Ischi about the best approach to selecting testing equipment for oral solid dosage applications...
In this application note, Buchi discuss precise and robust calibration models for determining the active ingredient content of tablets...
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
